Eli Lilly reported strong earnings for the second quarter, beating on the top and bottom lines. Disappointing trial results for orforglipron led to a sharp crash in its share price on Thursday. The ...

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.

Eli Lilly stock has generated fantastic returns for investors over the past five years. The company possesses many lucrative growth opportunities to ensure it remains an excellent buy in the years ...